首页 >
法规速递
-
Document: PhV non-compliance notification contact points at National Competent Authority (NCA) level-2025/3/24
2025-03-25查看详情 > -
Page: CHMP opinions on consultation procedures-2025/4/24
2025-04-27查看详情 > -
Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program - Final Guidance for Industry and Food and Drug Administration Staff-2025/5/29
2025-06-06查看详情 > -
Document: 2024 AI Observatory report: Compilation of 2024 experience-2025/7/10
2025-07-11查看详情 > -
Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development-2025/8/19
2025-08-20查看详情 > -
Document: Agenda of the PRAC meeting 29 September - 2 October 2025-2025/9/29
2025-09-30查看详情 > -
Page: Website outages and upgrades-2025/11/6
2025-11-07查看详情 > -
国家药监局关于发布仿制药参比制剂目录 （第九十九批）及调出参比制剂目录品种清单（第三批）的通告（2025年第44号）-2025/12/5
2025-12-08查看详情 > -
Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes-2026/1/15
2026-01-16查看详情 > -
Document: PDCO minutes of the 9-12 December 2025 meeting-2026/2/16
2026-02-26查看详情 >
